The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

The DEA Museum explores Bayer's early 20th-century marketing of heroin, originally promoted as a "less addictive" morphine alternative and cough suppressant. Initially hailed as a medical ...

Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for contrast-enhanced magnetic ...

The logo of German pharmaceuticals and chemicals giant Bayer stands over company offices in Berlin, Germany. 33,714 people played the daily Crossword recently. Can you solve it faster than others?